Skip to main content
SpringerLink
Log in

Athero-protective Effects of High Density Lipoproteins (HDL): An ODE Model of the Early Stages of Atherosclerosis

  • Original Article
  • Published:
Bulletin of Mathematical Biology Aims and scope Submit manuscript

Abstract

We present an ODE model which we use to investigate how High Density Lipoproteins (HDL) reduce the inflammatory response in atherosclerosis. HDL causes atherosclerotic plaque stabilisation and regression, and is an important potential marker and prevention target for cardiovascular disease. HDL enables cholesterol efflux from the arterial wall, macrophage and foam cell emigration, and has other athero-protective effects. Our basic inflammatory model is augmented to include several different ways that HDL can act in early atherosclerosis. In each case, the action of HDL is represented via a parameter in the model. The long-term model behaviour is investigated through phase plane analysis and simulations. Our results indicate that only HDL-enabled cholesterol efflux can stabilise the internalised lipid content in the lesion so that it does not continue to grow, but this does not reduce macrophage numbers which is required to stabilise the lesion or prevent rupture. HDL-enabled macrophage emigration guarantees lesion stabilisation by maintaining stable macrophage content.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Aicher, B. O., Haser, E. K., Freeman, L. A., Carnie, A. V., Stonik, J. A., Wang, X., Remaley, A. T., Kato, G. J., & Canon, R. O. III (2012). Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function. Obesity, 20(10), 2057–2062.

    Article  Google Scholar 

  • Ameli, S., Hultgardh-Nilsson, A., Cercek, B., Shah, P. K., Forrester, J. S., Ageland, H., & Nilsson, J. (1994). Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation, 90(4), 1935–1941.

    Article  Google Scholar 

  • Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G., Navab, M., & Fogelman, A. M. (2004). Anti-inflammatory properties of HDL. Circ. Res., 95(8), 764–772.

    Article  Google Scholar 

  • Berrougui, H., Isabelle, M., Cloutier, M., Grenier, G., & Khalil, A. (2007). Age-related impairment of HDL-mediated cholesterol efflux. J. Lipid Res., 48(2), 328–336.

    Article  Google Scholar 

  • Cobbold, C. A., Sherratt, J. A., & Maxwell, S. R. J. (2002). Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach. Bull. Math. Biol., 64, 65–95.

    Article  Google Scholar 

  • Dansky, H. M., & Fisher, E. A. (1999). High-density lipoprotein and plaque regression: the good cholesterol gets even better. Circulation, 100(17), 1762–1763.

    Article  Google Scholar 

  • Duffy, D., & Rader, D. J. (2006). Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation, 113(8), 1140–1150.

    Article  Google Scholar 

  • Ellison, R. C., Zhang, Y., Qureshi, M. M., Knox, S., Arnett, D. K., & Province, M. A. (2004). Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am. Heart J., 147(3), 529–535.

    Article  Google Scholar 

  • Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999). Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Circulation, 100(6), 594–598.

    Article  Google Scholar 

  • Feig, J. E., Rong, J. X., Shamir, R., Sanson, M., Vengrenyuk, Y., Liu, J., Rayner, K., Moore, K., Garabedian, M., & Fisher, E. A. (2011). HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl. Acad. Sci. USA, 108(17), 7166–7171.

    Article  Google Scholar 

  • Hansson, G. K., & Libby, P. (2006). The immune response in atherosclerosis: a double-edged sword. Nat. Immunol., 6, 508–519.

    Article  Google Scholar 

  • Joy, T., & Hegele, R. (2008). Is raising HDL a futile strategy for atheroprotection?. Nat. Rev. Drug Discov., 7, 143–155.

    Article  Google Scholar 

  • Kennedy, M. A., Barrera, G. C., Nakamura, K., Baldan, A., Tarr, P., Fishbein, M. C., Frank, J., Francone, O. L., & Edwards, P. A. (2005). ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metabolism, 1, 121–131.

    Article  Google Scholar 

  • Kharbanda, R., & MacAllister, R. (2005). The atherosclerosis time-line and the role of the endothelium. Curr. Medicine Chem., 5, 47–52.

    Google Scholar 

  • Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S., Silverstein, R., Hoff, H. F., & Freeman, M. W. (2002). Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem., 277(51), 49982–49988.

    Article  Google Scholar 

  • Lee, J. M., & Choudhury, R. P. (2007). Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets. Heart, 93, 559–564.

    Article  Google Scholar 

  • Lendon, C. L., Davies, M. J., Born, G. V. R., & Richardson, P. D. (1991). Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis, 87(1), 87–90.

    Article  Google Scholar 

  • Libby, P., & Ridker, P. M. (2006). Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J. Am. Coll. Cardiol., 48, A33–A46.

    Article  Google Scholar 

  • Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation, 105, 1135–1143.

    Article  Google Scholar 

  • Linsel-Nitschke, P., & Tall, A. (2005). HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov., 4, 193–205.

    Article  Google Scholar 

  • Liu, H., Shi, B., Huang, C.-C., Eksarko, P., & Pope, R. M. (2008). Transcriptional diversity during monocyte to macrophage differentiation. Immunol. Lett., 117(1), 70–80.

    Article  Google Scholar 

  • Llodrá, J., Angeli, V., Liu, J., Trogan, E., Fisher, E. A., & Randolph, G. J. (2004). Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive plaques. Proc. Natl. Acad. Sci. USA, 101(32), 11779–11784.

    Article  Google Scholar 

  • Lusis, A. J. (2000). Atherosclerosis. Nature, 407, 233–241.

    Article  Google Scholar 

  • Morton, J., Bao, S., Celermajer, D. S., Ng, M. K., & Bursill, C. A. (2013). Strikingly different atheroprotective effects of apoliprotein A-I in early-stage versus late-stage atherosclerosis. Circulation, 128, A15785.

    Google Scholar 

  • Navab, M., Anantharamaiah, G., Reddy, S. T., Lenten, B. J. V., & Fogelman, A. M. (2009). HDL as a biomarker, potential therapeutic target, and therapy. Diabetes, 58(12), 2711–2717.

    Article  Google Scholar 

  • Nicholls, S. J. (2012). The aim-high (atherothrombosis intervention in metabolic syndrome with low HDL/high triglycerides: impact on global health outcomes) trial. To believe or not to believe? J. Am. Coll. Cardiol., 59(23), 2065–2067.

    Article  Google Scholar 

  • Nicholson, A. C., Han, J., Febbraio, M., Silverstein, R. L., & Hajjar, D. P. (2001). Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann. N.Y. Acad. Sci., 947(1), 224–228.

    Article  Google Scholar 

  • Nissen, S. E., Tardif, J.-C., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Ruzyllo, W., Bachinsky, W. B., Lasala, G. P., Tuzcu, E. M., & ILLUSTRATE Investigators (2007). Effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med., 356(13), 1304–1316.

    Article  Google Scholar 

  • Ougrinovskaia, A., Thompson, R. S., & Myerscough, M. R. (2010). An ODE model of early stages of atherosclerosis: mechanisms of the inflammatory response. Bull. Math. Biol., 72(6), 1534–1561.

    Article  MathSciNet  MATH  Google Scholar 

  • Parolini, G. C. C., & Marchesi, M. (2009). HDL therapy for the treatment of cardiovascular diseases. Curr. Vasc. Pharmacol., 7(4), 550–556.

    Article  Google Scholar 

  • Reis, E. D., Li, J., Fayad, Z. A., Rong, J. X., Hansoty, D., Aguinaldo, J.-G., Fallon, J. T., & Fisher, E. A. (2001). Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J. Vasc. Surg., 34(3), 541–547.

    Article  Google Scholar 

  • Rong, J. X., Li, J., Reis, E. D., Choudhury, R. P., Dansky, H. M., Elmalem, V. I., Fallon, J. T., Breslow, J. L., & Fisher, E. A. (2001). Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation, 104(20), 2447–2452.

    Article  Google Scholar 

  • Ross, R. (1999). Atherosclerosis—an inflammatory disease. N. Engl. J. Med., 340, 115–126.

    Article  Google Scholar 

  • Singh, I. M., Shishehbor, M. H., & Ansell, B. J. (2007). High-density lipoprotein as a therapeutic target: a systematic review. JAMA J. Am. Med. Assoc., 298(7), 786–798.

    Article  Google Scholar 

  • Sirtori, C., & Fumagalli, R. (2006). LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention: a lesson from cholesterol turnover studies and others. Atherosclerosis, 186, 1–11.

    Article  Google Scholar 

  • Soma, M. R., Donetti, E., Parolini, C., Sirtori, C. R., Fumagalli, R., & Franceschini, G. (1995). Recombinant apolipoprotein A-I Milano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ. Res., 76(3), 405–411.

    Article  Google Scholar 

  • Stary, H. C., Chandler, A. B., Glagov, S., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994). A definition of initial, fatty streak and intermediate lesions of atherosclerosis—a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 89(5), 2462–2478.

    Article  Google Scholar 

  • Thompson, P. D., & Rader, D. J. (2001). Does exercise increase HDL cholesterol in those who need it the most? Arterioscler. Thromb. Vasc. Biol., 21(7), 1097–1098.

    Article  Google Scholar 

  • Trogan, E., Feig, J. E., Dogan, S., Rothblat, G. H., Angeli, V., Tacke, F., Randolph, G. J., & Fisher, E. A. (2006). Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. USA, 103(10), 3781–3786.

    Article  Google Scholar 

  • White, C., Datta, G., Zhang, Z., Gupta, H., Garber, D., Mishra, V., Palgunachari, M., Handattu, S., Chaddha, M., & Anantharamaiah, G. (2008). HDL therapy for cardiovascular diseases: the road to HDL mimetics. Curr. Atheroscl. Rep., 10, 405–412.

    Article  Google Scholar 

  • Williams, K. J., Feig, J. E., & Fisher, E. A. (2008). Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat. Clin. Pract. Cardiovasc. Med., 5(2), 91–102.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Mathematics and Statistics, University of Sydney, Sydney, NSW, 2006, Australia

    Anna Cohen, Mary R. Myerscough & Rosemary S. Thompson

Authors
  1. Anna Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary R. Myerscough
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rosemary S. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary R. Myerscough.

Additional information

Anna Cohen, née Ougrinovskaia.

Rose Thompson passed away on Sunday, April 8, 2012.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, A., Myerscough, M.R. & Thompson, R.S. Athero-protective Effects of High Density Lipoproteins (HDL): An ODE Model of the Early Stages of Atherosclerosis. Bull Math Biol 76, 1117–1142 (2014). https://doi.org/10.1007/s11538-014-9948-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11538-014-9948-4

Keywords

Search

Navigation